Open Access
Issue
Parasite
Volume 32, 2025
Article Number 31
Number of page(s) 7
DOI https://doi.org/10.1051/parasite/2025023
Published online 21 May 2025
  1. Ades AE, Nokes DJ. 1993. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. American Journal of Epidemiology, 137, 1022–1034. [CrossRef] [PubMed] [Google Scholar]
  2. Ancelle T, Yera H, Talabani H, Lebuisson A, Thulliez P, Dupouy-Camet J. 2009. Comment réduire le coût du dépistage de la toxoplasmose chez la femme enceinte ? Revue d’Épidémiologie et de Santé Publique, 57, 411–417. [CrossRef] [Google Scholar]
  3. Avelino MM, Campos D, Jr., de Parada J do CB, de Castro AM. 2003. Pregnancy as a risk factor for acute toxoplasmosis seroconversion. European Journal of Obstetrics and Gynecology and Reproductive Biology, 108, 19–24. [CrossRef] [Google Scholar]
  4. Bigna JJ, Tochie JN, Tounouga DN, Bekolo AO, Ymele NS, Youda EL, Sime PS, Nansseu JR. 2020. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis. Scientific Reports, 10, 12102. [CrossRef] [PubMed] [Google Scholar]
  5. Blaga R, Aubert D, Thébault A, Perret C, Geers R, Thomas M, Alliot A, Djokic V, Ortis N, Halos L, Durand B, Mercier A, Villena I, Boireau P. 2019. Toxoplasma gondii in beef consumed in France: regional variation in seroprevalence and parasite isolation. Parasite, 26, 77. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Cook AJC, Holliman R, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT. 2000. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. BMJ, 321, 142. [CrossRef] [PubMed] [Google Scholar]
  7. Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D’Amico R, Magrini N. 2015. Prenatal education for congenital toxoplasmosis. Cochrane Database of Systematic reviews CD006171. [Google Scholar]
  8. Djokic V, Blaga R, Aubert D, Durand B, Perret C, Geers R, Ducry T, Vallee I, Djurkovic Djakovic O, Mzabi A, Villena I, Boireau P. 2016. Toxoplasma gondii infection in pork produced in France. Parasitology, 143, 557–567. [CrossRef] [PubMed] [Google Scholar]
  9. Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. 2018. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clinical Microbiology Reviews, 31, e00057-17. [CrossRef] [PubMed] [Google Scholar]
  10. Enquête nationale périnatale : résultats de l’édition. 2021. Available from: https://www.santepubliquefrance.fr/presse/2022/enquete-nationale-perinatale-resultats-de-l-edition-2021. [Google Scholar]
  11. Fédération des fabricants d’aliments pour chiens, chats, oiseaux et autres animaux familiers (FACCO). 2023. Les chiffres de la population animale en France. Available from: https://www.facco.fr/chiffres-cles/les-chiffres-de-la-population-animale/. [Google Scholar]
  12. Halos L, Thébault A, Aubert D, Thomas M, Perret C, Geers R, Alliot A, Escotte-Binet S, Ajzenberg D, Dardé ML, Durand B, Boireau P, Villena I. 2010. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France. International Journal for Parasitology, 40, 193–200. [CrossRef] [PubMed] [Google Scholar]
  13. Institut National de la statistique et des études économiques (INSEE). 2023. 7-level municipal density grid. Available from: https://www.insee.fr/fr/statistiques/6686472. [Google Scholar]
  14. Journé A, Garweg J, Ksiazek E, Peyron F, Binquet C, Wallon M. 2024. Long-term ocular outcomes in congenital toxoplasmosis treated perinatally. Pediatrics, 153, e2023064114. [CrossRef] [PubMed] [Google Scholar]
  15. Milne GC, Webster JP, Walker M. 2023. Is the incidence of congenital toxoplasmosis declining? Trends in Parasitology, 39, 26–37. [CrossRef] [PubMed] [Google Scholar]
  16. Nogareda F, Le Strat Y, Villena I, De Valk H, Goulet V. 2014. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation. Epidemiology and Infection, 142, 1661–1670. [CrossRef] [PubMed] [Google Scholar]
  17. Opsteegh M, Kortbeek TM, Havelaar AH, van der Giessen JWB. 2015. Intervention strategies to reduce human Toxoplasma gondii disease burden. Clinical Infectious Diseases, 60, 101–107. [CrossRef] [PubMed] [Google Scholar]
  18. Robinson E, de Valk H, Villena I, Le Strat Y, Tourdjman M. 2021. National perinatal survey demonstrates a decreasing seroprevalence of Toxoplasma gondii infection among pregnant women in France, 1995 to 2016: impact for screening policy. Eurosurveillance, 26, 1900710. [CrossRef] [Google Scholar]
  19. Sawers L, Wallon M, Mandelbrot L, Villena I, Stillwaggon E, Kieffer F. 2022. Prevention of congenital toxoplasmosis in France using prenatal screening: A decision-analytic economic model. PLoS One, 17, e0273781. [CrossRef] [PubMed] [Google Scholar]
  20. Service de la Statistique et de la Prospective du ministère de l’Agriculture et de l’Alimentation (AGRESTE). 2022. La consommation de viande en France en 2022. Available from: https://agreste.agriculture.gouv.fr/agreste-web/download/publication/publie/SynCsm23412/consyn412202307-ConsoViande.pdf. [Google Scholar]
  21. Stelzer S, Basso W, Benavides Silván J, Ortega-Mora LM, Maksimov P, Gethmann J, Conraths FJ, Schares G. 2019. Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact. Food and Waterborne Parasitology, 15, e00037. [CrossRef] [PubMed] [Google Scholar]
  22. Toxoplasmosis Report. 2022. National Centre for Toxoplasmosis - CHU de Reims, France. Available from: http://cnrtoxoplasmose.chu-reims.fr/wp-content/uploads/2023/03/Reims-Dossier-de-candidature-CNR-Toxoplasmose-volet-scientifique.pdf. [Google Scholar]
  23. Vasarri MV, Fernicola F, Arienti F, Carli A, Colciago E, Locatelli A, Rotta M, Procopio A, Zammarchi L, Ornaghi S. 2024. Indirect impact of SARS-CoV-2 pandemic on incidence of maternal primary cytomegalovirus and Toxoplasma gondii infection in pregnancy. International Journal of Gynecology and Obstetricts, 166, 1218–1224. [CrossRef] [PubMed] [Google Scholar]
  24. Wallon M, Kieffer F, Peyron F, Mandelbrot L, Garweg JG. 2024. Toxoplasmosis. Remington and Klein’s infectious diseases of the fetus and newborn infant (9th edn.). Elsevier Health Sciences. [Google Scholar]
  25. Wallon M, Ksiazek E, Journé A, Dupont D, Menotti J, Peyron F, Binquet C. 2024. Congenital toxoplasmosis: Fewer clinical signs at 3 years of age over the last 15 years but stable risk of materno-fetal transmission. Clinical Infectious Diseases, ciae634. [Google Scholar]
  26. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. 2013. Congenital Toxoplasma infection: Monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clinical Infectious Diseases, 56, 1223–1231. [CrossRef] [PubMed] [Google Scholar]
  27. Zhou Y, Leahy K, Grose A, Lykins J, Siddiqui M, Leong N, Goodall P, Withers S, Ashi K, Schrantz S, Tesic V, Abeleda AP, Beavis K, Clouser F, Ismail M, Christmas M, Piarroux R, Limonne D, Chapey E, Abraham S, Baird I, Thibodeau J, Boyer KM, Torres E, Conrey S, Wang K, Staat MA, Back N, L’Ollivier C, Mahinc C, Flori P, Gomez-Marin J, Peyron F, Houzé S, Wallon M, McLeod R. 2024. Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and more. PLoS Neglected Tropical Diseases, 18, e0011335. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.